Carol Poortman
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging
- Immunology
- Endocrinology, Diabetes and Metabolism
- Oncology
- Co-authors
- Tom J. ParryLes SekutBonnie SturmGuoxian ChenBlaire L. OsbornMarta L. CorcoranYuling LiR. Miceli
- Topics
- Virus-based gene therapy research (2 papers)Cell death mechanisms and regulation (2 papers)CAR-T cell therapy research (2 papers)
- Journals
- Cancer ResearchJournal of Pharmacology and Experimental TherapeuticsEuropean Journal of Pharmacology
- Partner nations
- United States
In The Last Decade
Carol Poortman
7 papers receiving 144 citations
Peers
Comparison fields: 5 of 46
- Molecular Biology 82
- Radiology, Nuclear Medicine and Imaging 51
- Immunology 44
- Endocrinology, Diabetes and Metabolism 30
- Oncology 23
Countries citing papers authored by Carol Poortman
This map shows the geographic impact of Carol Poortman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Poortman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Poortman more than expected).
Fields of papers citing papers by Carol Poortman
This network shows the impact of papers produced by Carol Poortman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Poortman. The network helps show where Carol Poortman may publish in the future.
Co-authorship network of co-authors of Carol Poortman
This figure shows the co-authorship network connecting the top 25 collaborators of Carol Poortman. A scholar is included among the top collaborators of Carol Poortman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Poortman. Carol Poortman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 3 | |
| 4 | HGS-TR2J, an agonistic, TRAIL receptor 2 monoclonal antibody, actively and rapidly stimulates the TRAIL receptor pathway that leads to significant inhibition of tumor growth in human tumor cell lines in vitro and in vivo | 2 |
| 5 | 6 | |
| 6 | 96 | |
| 7 | 38 |
About Carol Poortman
Carol Poortman is a scholar working on Biotechnology, Immunology and Oncology, having authored 7 papers that have together received 152 indexed citations. Recurring topics across this work include Virus-based gene therapy research (2 papers), Cell death mechanisms and regulation (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (51 citations), Immunology (44 citations) and Endocrinology, Diabetes and Metabolism (30 citations). Carol Poortman has collaborated with scholars based in United States. Frequent co-authors include Tom J. Parry, Les Sekut, Bonnie Sturm, Guoxian Chen, Blaire L. Osborn, Marta L. Corcoran, Yuling Li, R. Miceli, Svetlana Sosnovtseva and James Fikes. Their work appears in journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.